Aardens Biosciences is rated 3 out of 5 in the category research. Read and write reviews about Aardens Biosciences. Aardens provides state-of-the-art research data management systems and data analysis tools for academic institutions, pharma and biotech companies. Aardens’ data capture systems intended for genomics research where, besides DNA samples, associated clinical and patient data need to be collected. In this field we cannot avoid dealing with both data protection and privacy questions. At the same time, we at Aardens, believe that transparency should reach genomics research as well. Our team is dedicated of using cutting edge blockchain technologies in order to decentralize data storage and make interactions visible. Leaning on the new data protection regulation of European Union (GDPR), Aardens has developed a cutting edge dynamic patient consent method using smartcontract technology. We believe that our technology may become industry standard in the near future not just in Europe but also in North America. Aardens’s core competancies: - Big data technologies such as predictive analytics for biomarker discovery in pharma and biotech R&D. - Data management and storage systems using blockchain based decentralised data storage solutions. - Machine learning technics using multi-markers for medical decision making. - Bioinformatics for high-throughput ‘omics’ data processing including genomics, transcriptomics, epigenomics, metagenomics, proteomics and metabolomics data. - Biobank systems for large-scale data gathering, data integration, visualization and data interpretation.
Company size
1-10 employees
Headquarters
Tallinn, Harju